High hENT1 expression was also associated with longer overall survival (OS) among patients with pancreatic cancer treated with both palliative and adjuvant GEM (11, 12) and vice versa (13, 14). This evidence concerns the gene SLC29A1 and familial pancreatic carcinoma.